Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-71,583
Closed -$1.6M 2734
2016
Q1
$1.6M Buy
71,583
+59,895
+512% +$1.34M 0.01% 949
2015
Q4
$323K Buy
11,688
+2,964
+34% +$81.9K ﹤0.01% 1754
2015
Q3
$225K Sell
8,724
-8,962
-51% -$231K ﹤0.01% 1888
2015
Q2
$438K Buy
17,686
+6,509
+58% +$161K ﹤0.01% 1614
2015
Q1
$282K Sell
11,177
-2,460
-18% -$62.1K ﹤0.01% 1629
2014
Q4
$320K Sell
13,637
-378
-3% -$8.87K ﹤0.01% 1501
2014
Q3
$319K Sell
14,015
-2,377
-15% -$54.1K ﹤0.01% 1577
2014
Q2
$401K Buy
16,392
+6,918
+73% +$169K ﹤0.01% 1365
2014
Q1
$200K Sell
9,474
-49
-0.5% -$1.03K ﹤0.01% 1739
2013
Q4
$227K Sell
9,523
-23,780
-71% -$567K ﹤0.01% 1525
2013
Q3
$712K Buy
33,303
+21,000
+171% +$449K 0.01% 1064
2013
Q2
$245K Buy
+12,303
New +$245K ﹤0.01% 1410

Other funds holding QGENF

Jefferies Group's QGENF Position: Q2 2016 in Review

Jefferies Group sold out of QIAGEN NV (QGENF) in Q2 2016, closing a stake of 71,583 shares — an estimated $1.6M sold.

Jefferies Group first reported a position in QGENF in Q2 2013 and held it in 12 quarters. The position peaked at $1.6M in Q1 2016. 188 funds tracked by Wall St. Rank hold QGENF as of Q2 2016.

  • Jefferies Group reported no remaining QIAGEN NV position as of Q2 2016 after selling out during the quarter.
  • Jefferies Group sold 71,583 QIAGEN NV shares in Q2 2016, an estimated $1.6M.
  • Jefferies Group first reported a position in QIAGEN NV in Q2 2013 and held it in 12 quarters.
  • Jefferies Group's QIAGEN NV position peaked at $1.6M in Q1 2016.
  • 188 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2016.

Based on Jefferies Group's 13F filing for Q2 2016, filed 12 Aug 2016.